COVAXX
Latest round
- Seed
Last raised
- Mar 2020
Total raised
- Undisclosed
Investors
- 1
About COVAXX
COVAXX is dedicated to creating immunotherapeutic products that target neurological conditions. The company was founded by Lou Reese, Max Fox, Mei Hu, and Peter Diamandis. Mei Hu currently serves as the CEO.COVAXX specializes in developing and commercializing immunotherapeutic products, focusing primarily on treating neurological diseases with peptide-based vaccines. These vaccines stimulate the immune system to combat conditions like Alzheimer’s disease, aiming to improve patient outcomes.COVAXX generates revenue by collaborating with research institutions and pharmaceutical companies through B2B transactions, primarily via joint development agreements. Additionally, the company aims to expand into European markets and increase its presence in North America by 2022.
Who invested in COVAXX
1 investor across 1 round
See all investors in COVAXX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 25, 2020
Amount
Undisclosed
Investors
Questions about COVAXX
Who invested in COVAXX?
COVAXX has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has COVAXX raised?
COVAXX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did COVAXX last raise money?
COVAXX's most recent round on record is a Seed, in Mar 2020.
What does COVAXX do?
COVAXX is dedicated to creating immunotherapeutic products that target neurological conditions.
Where is COVAXX headquartered?
COVAXX is headquartered in US.
Which VCs invest in companies like COVAXX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at COVAXX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like COVAXX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.